Financial Snapshot

Revenue
$870.7K
TTM
Gross Margin
92.39%
TTM
Net Earnings
-$24.80M
TTM
Current Assets
Q3 2024
Current Liabilities
Q3 2024
Current Ratio
17.4%
Q3 2024
Total Assets
Q3 2024
Total Liabilities
$18.73M
Q3 2024
Book Value
-$13.47M
Q3 2024
Cash
Q3 2024
P/E
-0.6991
Nov 29, 2024 EST
Free Cash Flow
-$4.297M
TTM

Revenues

Revenues

Loading...

Revenue YoY Change

Loading...

Revenues

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998
Revenue $1.076M $1.376M $1.586M $903.4K $1.007M $1.011M $1.238M $1.503M $950.0K $1.570M $1.690M $1.040M $1.030M $800.0K $620.0K $500.0K $750.0K $540.0K $450.0K $470.0K $400.0K $520.0K $290.0K $350.0K $570.0K $280.0K
YoY Change -21.76% -13.24% 75.54% -10.31% -0.42% -18.28% -17.64% 58.2% -39.49% -7.1% 62.5% 0.97% 28.75% 29.03% 24.0% -33.33% 38.89% 20.0% -4.26% 17.5% -23.08% 79.31% -17.14% -38.6% 103.57%

Expenses

Cost Of Revenues

Loading...

Gross Profit

Loading...

Gross Profit Margin

Loading...

Gross Profit

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998
Revenue $1.076M $1.376M $1.586M $903.4K $1.007M $1.011M $1.238M $1.503M $950.0K $1.570M $1.690M $1.040M $1.030M $800.0K $620.0K $500.0K $750.0K $540.0K $450.0K $470.0K $400.0K $520.0K $290.0K $350.0K $570.0K $280.0K
Cost Of Revenue $98.46K $150.0K $166.8K $70.00K $80.00K $105.0K $132.9K $198.4K $160.0K $340.0K $470.0K $160.0K $300.0K $110.0K $110.0K $100.0K $100.0K $130.0K $70.00K $80.00K $50.00K $80.00K $30.00K $60.00K $80.00K $60.00K
Gross Profit $992.0K $1.226M $1.419M $830.0K $920.0K $906.5K $1.105M $1.304M $790.0K $1.230M $1.230M $890.0K $730.0K $690.0K $510.0K $400.0K $650.0K $420.0K $390.0K $390.0K $350.0K $440.0K $260.0K $290.0K $490.0K $220.0K
Gross Profit Margin 92.16% 89.1% 89.48% 91.88% 91.34% 89.62% 89.26% 86.8% 83.16% 78.34% 72.78% 85.58% 70.87% 86.25% 82.26% 80.0% 86.67% 77.78% 86.67% 82.98% 87.5% 84.62% 89.66% 82.86% 85.96% 78.57%

Selling, General & Admin Expense

Loading...

Research & Development

Loading...

Depreciation, Depletion & Amortization

Loading...

SGA Expense to Gross Profit Ratio

Loading...

R&D To Gross Profit Ratio

Loading...

DDA To Gross Profit Ratio

Loading...

Operating Expenses Total

Loading...

Operating Profits/Loss

Loading...

Operational Expenses

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998
Selling, General & Admin $6.827M $7.829M $6.538M $3.680M $3.440M $2.440M $2.630M $2.650M $2.230M $1.550M $650.0K $570.0K $780.0K $680.0K $690.0K $520.0K $430.0K $350.0K $500.0K $670.0K $290.0K $240.0K $280.0K $380.0K $390.0K $180.0K
YoY Change -12.8% 19.73% 77.67% 6.98% 40.98% -7.22% -0.75% 18.83% 43.87% 138.46% 14.04% -26.92% 14.71% -1.45% 32.69% 20.93% 22.86% -30.0% -25.37% 131.03% 20.83% -14.29% -26.32% -2.56% 116.67%
% of Gross Profit 688.18% 638.65% 460.79% 443.37% 373.91% 269.18% 238.04% 203.15% 282.28% 126.02% 52.85% 64.04% 106.85% 98.55% 135.29% 130.0% 66.15% 83.33% 128.21% 171.79% 82.86% 54.55% 107.69% 131.03% 79.59% 81.82%
Research & Development $14.18M $9.000M $9.154M $6.096M $4.869M $2.711M $2.293M $1.865M $660.0K $90.00K
YoY Change 57.58% -1.68% 50.15% 25.21% 79.59% 18.25% 22.96% 182.53% 633.33%
% of Gross Profit 1429.56% 734.17% 645.1% 734.51% 529.26% 299.11% 207.53% 142.95% 83.54% 7.32%
Depreciation & Amortization $19.28K $19.48K $16.83K $12.76K $5.681K $10.12K $9.271K $107.1K $170.0K $150.0K $150.0K $140.0K $30.00K $20.00K $20.00K $20.00K $20.00K $30.00K $40.00K $30.00K $30.00K $20.00K $50.00K $30.00K $20.00K $10.00K
YoY Change -1.05% 15.77% 31.84% 124.66% -43.89% 9.2% -91.34% -37.0% 13.33% 0.0% 7.14% 366.67% 50.0% 0.0% 0.0% 0.0% -33.33% -25.0% 33.33% 0.0% 50.0% -60.0% 66.67% 50.0% 100.0%
% of Gross Profit 1.94% 1.59% 1.19% 1.54% 0.62% 1.12% 0.84% 8.21% 21.52% 12.2% 12.2% 15.73% 4.11% 2.9% 3.92% 5.0% 3.08% 7.14% 10.26% 7.69% 8.57% 4.55% 19.23% 10.34% 4.08% 4.55%
Operating Expenses $14.18M $9.000M $9.154M $6.096M $4.869M $2.711M $2.293M $1.865M $3.060M $1.790M $800.0K $710.0K $810.0K $700.0K $710.0K $540.0K $460.0K $350.0K $490.0K $670.0K $280.0K $250.0K $280.0K $380.0K $390.0K $240.0K
YoY Change 57.58% -1.68% 50.15% 25.21% 79.59% 18.25% 22.96% -39.06% 70.95% 123.75% 12.68% -12.35% 15.71% -1.41% 31.48% 17.39% 31.43% -28.57% -26.87% 139.29% 12.0% -10.71% -26.32% -2.56% 62.5%
Operating Profit -$20.05M -$15.62M -$14.29M -$8.961M -$7.545M -$4.267M -$3.843M -$4.206M -$2.270M -$560.0K $430.0K $180.0K -$80.00K -$10.00K -$200.0K -$140.0K $190.0K $70.00K -$100.0K -$280.0K $70.00K $190.0K -$20.00K -$90.00K $100.0K -$20.00K
YoY Change 28.35% 9.32% 59.46% 18.78% 76.82% 11.02% -8.62% 85.28% 305.36% -230.23% 138.89% -325.0% 700.0% -95.0% 42.86% -173.68% 171.43% -170.0% -64.29% -500.0% -63.16% -1050.0% -77.78% -190.0% -600.0%

Interest Expenses

Loading...

Interest Expenses To Operating Income %

Loading...

Other Expense/Income

Loading...

Interest & Other Expense/Income

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998
Interest Expense -$7.250K $12.47K $3.410K $20.00K $10.00K $10.00K $28.60K -$20.00K -$30.00K -$50.00K -$60.00K -$20.00K $0.00 $10.00K $30.00K $10.00K $10.00K $0.00 $0.00 -$20.00K -$10.00K -$30.00K -$30.00K -$10.00K $10.00K
YoY Change -158.14% 265.69% -82.95% 100.0% 0.0% -243.02% -33.33% -40.0% -16.67% 200.0% -100.0% -66.67% 200.0% 0.0% -100.0% 100.0% -66.67% 0.0% 200.0% -200.0%
% of Operating Profit -11.63% -33.33% 5.26% 14.29% -28.57% -5.26% -10.0%
Other Income/Expense, Net -$7.245K $12.47K $3.405K $19.80K $11.77K $10.26K -$17.95K $0.00 $0.00
YoY Change -158.08% 266.34% -82.8% 14.74% -157.15%

Income/Loss

Pretax Income

Loading...

Income Tax

Loading...

Net Profits/Loss

Loading...

Pretax Income YoY Change

Loading...

Income Tax Rate

Loading...

Net Profits/Loss YoY Change

Loading...

Basic EPS

Loading...

Net Income To Revenue Ratio

Loading...

Pretax & Net Income

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998
Pretax Income -$20.06M -$15.45M -$14.29M -$8.942M -$7.533M -$4.255M -$3.833M -$4.224M -$2.430M -$590.0K $280.0K $100.0K -$100.0K -$10.00K -$190.0K -$210.0K $200.0K -$100.0K $50.00K -$560.0K $50.00K $170.0K -$60.00K -$120.0K $90.00K -$80.00K
YoY Change 29.81% 8.15% 59.78% 18.71% 77.03% 11.01% -9.25% 73.82% 311.86% -310.71% 180.0% -200.0% 900.0% -94.74% -9.52% -205.0% -300.0% -300.0% -108.93% -1220.0% -70.59% -383.33% -50.0% -233.33% -212.5%
Income Tax $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $120.0K $0.00 $80.00K $30.00K $0.00 $30.00K $0.00 $200.0K -$450.0K $0.00 $230.0K $0.00 -$230.0K $0.00 $0.00 $200.0K $20.00K $40.00K
% Of Pretax Income 28.57% 30.0% -225.0% 460.0% -460.0% 0.0% 22.22%
Net Earnings -$20.06M -$15.45M -$14.29M -$8.942M -$7.533M -$4.255M -$3.833M -$4.224M -$2.550M -$590.0K $200.0K $70.00K -$100.0K -$40.00K -$190.0K -$410.0K $650.0K -$100.0K -$170.0K -$560.0K $270.0K $170.0K -$110.0K -$510.0K $70.00K -$110.0K
YoY Change 29.81% 8.15% 59.78% 18.71% 77.03% 11.01% -9.25% 65.64% 332.2% -395.0% 185.71% -170.0% 150.0% -78.95% -53.66% -163.08% -750.0% -41.18% -69.64% -307.41% 58.82% -254.55% -78.43% -828.57% -163.64%
Net Earnings / Revenue -1863.36% -1123.08% -900.94% -989.8% -747.87% -420.68% -309.68% -281.04% -268.42% -37.58% 11.83% 6.73% -9.71% -5.0% -30.65% -82.0% 86.67% -18.52% -37.78% -119.15% 67.5% 32.69% -37.93% -145.71% 12.28% -39.29%
Basic Earnings Per Share -$1.23 -$1.83 -$2.24
Diluted Earnings Per Share -$1.23 -$1.83 -$2.243M -$5.587M -$6.972M -$5.195M -$5.319M -$6.698M -$4.554M -$1.157M $540.5K $189.2K -$277.8K -$117.6K -$655.2K -$1.708M $3.611M -$666.7K -$1.417M -$8.000M $5.400M $3.400M -$2.750M -$12.75M $3.500M -$11.00M

Assets & Liabilities

Cash & Short-Term Investments

Loading...

Cash & Equivalents

Loading...

Cash To Operating Expenses Ratio

Loading...

Inventory

Loading...

Receivables

Loading...

Total Short-Term Assets

Loading...

Property, Plant And Equipment

Loading...

Long-Term Investments

Loading...

Total Long-Term Assets

Loading...

Total Assets

Loading...

Net Income To Total Assets Percentage

Loading...

Accounts Payable

Loading...

Short-Term Debt

Loading...

Long Term Debt Due

Loading...

Total Short-Term Liabilities

Loading...

Long-Term Debt

Loading...

Other Long-Term Liabilities

Loading...

Total Long-Term Liabilities

Loading...

Total Liabilities

Loading...

Short-Term To Long-Term Debt Ratio

Loading...

Short-Term Assets To Debt Ratio

Loading...

Long-Term Debt To Net Income Ratio

Loading...

Assets & Liabilities

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998
Cash & Short-Term Investments $9.247M $1.543M $16.61M $12.85M $2.780M $2.220M $1.270M $960.0K $1.840M $2.380M $270.0K $20.00K $130.0K $110.0K $340.0K $280.0K $310.0K $160.0K $190.0K $90.00K $10.00K $50.00K $10.00K $20.00K $70.00K
YoY Change 499.1% -90.71% 29.28% 362.23% 25.23% 74.8% 32.29% -47.83% -22.69% 781.48% 1250.0% -84.62% 18.18% -67.65% 21.43% -9.68% 93.75% -15.79% 111.11% 800.0% -80.0% 400.0% -50.0% -71.43%
Cash & Equivalents $9.247M $1.543M $16.61M $12.85M $2.780M $2.220M $1.270M $960.0K $1.840M $2.380M $270.0K $20.00K $130.0K $110.0K $340.0K $280.0K $210.0K $20.00K $30.00K $90.00K $10.00K $50.00K $10.00K $20.00K $70.00K
Short-Term Investments $0.00 $100.0K $140.0K $160.0K
Other Short-Term Assets $2.695M $2.306M $2.057M $850.0K $750.0K $20.00K $60.00K $50.00K $10.00K $10.00K $10.00K $10.00K $0.00 $10.00K $0.00 $0.00 $80.00K $20.00K $70.00K $50.00K $0.00 $10.00K $20.00K
YoY Change 16.88% 12.08% 142.01% 13.33% 3650.0% -66.67% 20.0% 400.0% 0.0% 0.0% 0.0% -100.0% -100.0% 300.0% 40.0% -100.0% -50.0%
Inventory $254.4K $254.5K $227.4K $240.0K $240.0K $420.0K $470.0K $500.0K $610.0K $580.0K $240.0K $210.0K $140.0K $180.0K $190.0K $210.0K $110.0K $80.00K $60.00K $50.00K $80.00K $60.00K $30.00K $60.00K $90.00K
Prepaid Expenses
Receivables $122.4K $54.99K $493.1K $70.00K $140.0K $80.00K $60.00K $90.00K $60.00K $80.00K $100.0K $70.00K $50.00K $80.00K $40.00K $30.00K $90.00K $60.00K $40.00K $60.00K $130.0K $40.00K $30.00K $10.00K $20.00K
Other Receivables $0.00 $0.00 $45.98K $40.00K $40.00K $40.00K $30.00K $30.00K $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $10.00K $10.00K $30.00K
Total Short-Term Assets $12.32M $4.159M $19.44M $14.05M $3.960M $2.770M $1.900M $1.640M $2.520M $3.050M $620.0K $300.0K $320.0K $370.0K $560.0K $520.0K $580.0K $320.0K $280.0K $270.0K $270.0K $150.0K $80.00K $100.0K $230.0K
YoY Change 196.21% -78.6% 38.34% 254.8% 42.96% 45.79% 15.85% -34.92% -17.38% 391.94% 106.67% -6.25% -13.51% -33.93% 7.69% -10.34% 81.25% 14.29% 3.7% 0.0% 80.0% 87.5% -20.0% -56.52%
Property, Plant & Equipment $929.3K $56.66K $77.22K $90.00K $60.00K $20.00K $30.00K $30.00K $1.650M $1.630M $1.610M $1.720M $1.330M $470.0K $440.0K $440.0K $330.0K $420.0K $430.0K $380.0K $340.0K $390.0K $420.0K $330.0K
YoY Change 1540.1% -26.63% -14.2% 50.0% 200.0% -33.33% 0.0% 1.23% 1.24% -6.4% 29.32% 182.98% 6.82% 0.0% 33.33% -21.43% -2.33% 13.16% 11.76% -12.82% -7.14% 27.27%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $0.00 $2.220M $590.0K $540.0K $710.0K $750.0K $230.0K $250.0K $270.0K $540.0K $90.00K $50.00K $290.0K $200.0K $10.00K $180.0K
YoY Change -100.0% 276.27% 9.26% -23.94% -5.33% 226.09% -8.0% -7.41% -50.0% 500.0% 80.0% -82.76% 45.0% 1900.0%
Total Long-Term Assets $929.3K $56.65K $84.49K $140.0K $150.0K $150.0K $190.0K $230.0K $2.220M $2.240M $2.170M $2.320M $2.470M $1.560M $740.0K $710.0K $1.020M $440.0K $480.0K $740.0K $590.0K $340.0K $390.0K $450.0K $540.0K
YoY Change 1540.39% -32.95% -39.65% -6.67% 0.0% -21.05% -17.39% -89.64% -0.89% 3.23% -6.47% -6.07% 58.33% 110.81% 4.23% -30.39% 131.82% -8.33% -35.14% 25.42% 73.53% -12.82% -13.33% -16.67%
Total Assets $13.25M $4.215M $19.52M $14.19M $4.110M $2.920M $2.090M $1.870M $4.740M $5.290M $2.790M $2.620M $2.790M $1.930M $1.300M $1.230M $1.600M $760.0K $760.0K $1.010M $860.0K $490.0K $470.0K $550.0K $770.0K
YoY Change
Accounts Payable $5.775M $3.481M $3.678M $3.540M $3.120M $1.930M $940.0K $340.0K $260.0K $120.0K $140.0K $80.00K $530.0K $90.00K $30.00K $70.00K $70.00K $50.00K $30.00K $20.00K $50.00K $20.00K $150.0K $180.0K $60.00K
YoY Change 65.9% -5.36% 3.9% 13.46% 61.66% 105.32% 176.47% 30.77% 116.67% -14.29% 75.0% -84.91% 488.89% 200.0% -57.14% 0.0% 40.0% 66.67% 50.0% -60.0% 150.0% -86.67% -16.67% 200.0%
Accrued Expenses $2.694M $0.00 $19.25K $20.00K $20.00K
YoY Change -100.0% -3.75% 0.0%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $700.0K $0.00 $0.00 $90.00K $100.0K $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $20.00K $30.00K $0.00
YoY Change -100.0% -100.0% -10.0% -100.0% -33.33%
Long-Term Debt Due $0.00 $133.7K $110.0K $0.00 $30.00K $790.0K $60.00K $140.0K $30.00K $10.00K $0.00 $0.00 $0.00 $10.00K $10.00K $30.00K $30.00K $10.00K $10.00K $20.00K $20.00K
YoY Change -100.0% 21.55% -100.0% -96.2% 1216.67% -57.14% 366.67% 200.0% -100.0% 0.0% -66.67% 0.0% 200.0% 0.0% -50.0% 0.0%
Total Short-Term Liabilities $8.468M $3.481M $3.831M $3.670M $3.140M $1.930M $940.0K $340.0K $1.000M $920.0K $200.0K $320.0K $650.0K $100.0K $30.00K $70.00K $80.00K $60.00K $40.00K $260.0K $80.00K $30.00K $180.0K $230.0K $110.0K
YoY Change 143.29% -9.14% 4.39% 16.88% 62.69% 105.32% 176.47% -66.0% 8.7% 360.0% -37.5% -50.77% 550.0% 233.33% -57.14% -12.5% 33.33% 50.0% -84.62% 225.0% 166.67% -83.33% -21.74% 109.09%
Long-Term Debt $0.00 $0.00 $18.03K $40.00K $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $800.0K $750.0K $710.0K $430.0K $0.00 $0.00 $160.0K $140.0K $150.0K $190.0K $220.0K $150.0K $160.0K $180.0K $190.0K
YoY Change -100.0% -54.93% -100.0% 6.67% 5.63% 65.12% -100.0% 14.29% -6.67% -21.05% -13.64% 46.67% -6.25% -11.11% -5.26%
Other Long-Term Liabilities $22.48K $0.00 $20.00K $40.00K $0.00 $70.00K $0.00 $110.0K $100.0K $60.00K $10.00K
YoY Change -100.0% -50.0% -100.0% 10.0% 66.67% 500.0%
Total Long-Term Liabilities $22.48K $0.00 $18.03K $60.00K $40.00K $0.00 $0.00 $0.00 $0.00 $0.00 $800.0K $750.0K $710.0K $430.0K $70.00K $0.00 $160.0K $140.0K $150.0K $190.0K $220.0K $260.0K $260.0K $240.0K $200.0K
YoY Change -100.0% -69.95% 50.0% -100.0% 6.67% 5.63% 65.12% 514.29% -100.0% 14.29% -6.67% -21.05% -13.64% -15.38% 0.0% 8.33% 20.0%
Total Liabilities $8.491M $3.481M $3.849M $3.740M $3.180M $1.930M $940.0K $340.0K $1.000M $920.0K $990.0K $1.070M $1.370M $530.0K $90.00K $70.00K $240.0K $200.0K $190.0K $440.0K $300.0K $290.0K $440.0K $460.0K $300.0K
YoY Change 143.93% -9.57% 2.91% 17.61% 64.77% 105.32% 176.47% -66.0% 8.7% -7.07% -7.48% -21.9% 158.49% 488.89% 28.57% -70.83% 20.0% 5.26% -56.82% 46.67% 3.45% -34.09% -4.35% 53.33%

Ownership

Basic Shares Outstanding

Loading...

Diluted Shares Outstanding

Loading...

Preferred Stock

Loading...

Treasury Stock Shares

Loading...

Stock Issuance & Repurchase

Loading...

Ownership Data

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998
Basic Shares Outstanding 16.33M 8.439M 6.370M
Diluted Shares Outstanding
Preferred Stock
Treasury Stock Shares

Return On Shareholders' Equity

Loading...

Book Value

Loading...

Free Cash Flow

Loading...

Free Cash Flow YoY

Loading...

Free Cash Flow Margin

Loading...

Dividends

Dividends

Loading...

Stock Price

Loading...
Market Cap: $17.339 Million

About Cyclo Therapeutics, Inc.

Cyclo Therapeutics, Inc. engages in the development of cyclodextrin-based biopharmaceuticals for the treatment of disease. The company is headquartered in Gainesville Florida, Florida and currently employs 8 full-time employees. The company went IPO on 2004-02-27. The firm is focused on developing transformative therapies for rare and neurological diseases with limited treatment options. The Company’s Trappsol Cyclo is a proprietary formulation of hydroxypropyl beta cyclodextrin. The company is an orphan drug designated product in the United States and Europe, and is the subject of four formal clinical trials for Niemann-Pick Disease Type C (NPC) disease. NPC is a rare and fatal autosomal recessive genetic disease resulting in disrupted cholesterol metabolism that impacts the brain, lungs, liver, spleen, and other organs. The firm is also engaged in conducting a Phase 2b clinical trial using Trappsol Cyclo intravenously in early Alzheimer’s disease (NCT05607615) based on encouraging data from an Expanded Access program for Alzheimer’s disease (NCT03624842).

Industry: Biological Products, (No Diagnostic Substances) Peers: Aprea Therapeutics, Inc. Aridis Pharmaceuticals, Inc. AXIM BIOTECHNOLOGIES, INC. BIOCEPT INC Calithera Biosciences, Inc. SOLENO THERAPEUTICS INC GYRE THERAPEUTICS, INC. Innovation Pharmaceuticals Inc.